Zyprexa may get FDA approval for teenagers

09/26/2007 | Bloomberg

The FDA could grant approval for the use of Eli Lilly & Co.'s Zyprexa to treat adolescents with mental illness, after the head of the FDA's psychiatry division concluded that the schizophrenia drug's benefits outweigh its risks. Thomas Laughren issued a memo in April overruling an FDA panel which advised the rejection of Zyprexa, but Laughren declined to comment on Lilly's pending application for the drug's approval.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX